CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERUS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $445.25M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
74.8%
151M of 202M shares
Institutional holders
185
35 new, 16 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 25 sales
Net sold $3.34M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Guy Levy | 9,828,700 | 5.10% | 13G (passive) | Mar 23, 2026 |
| ARK Investment Management LLC | 19,207,604 | 10.05% | 13G (passive) amendment | Jun 30, 2025 |
| Catherine D. Wood | 17,932,099 | 8.95% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 13,728,396 | 7.60% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CERS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 22,215,127 | 11.02% | $64.87M | +639,708 | 0.00% |
| ARK Investment Management LLC | 17,932,099 | 8.90% | $52.36M | −1,229,049 | 0.34% |
| Vanguard Capital Management LLC | 8,563,424 | 4.25% | $25.01M | +431,646 | 0.00% |
| Baker Bros. Advisors LP | 6,395,431 | 3.17% | $18.67M | −3,612,914 | 0.09% |
| D. E. Shaw & Co., Inc. | 5,485,983 | 2.72% | $16.02M | +1,754,832 | 0.01% |
| Geode Capital Management, LLC | 5,119,019 | 2.54% | $14.95M | +481,579 | 0.00% |
| State Street Corp | 4,753,962 | 2.36% | $13.88M | +539,060 | 0.00% |
| Senvest Management, LLC | 4,614,061 | 2.29% | $13.47M | +500,000 | 0.40% |
| Acadian Asset Management LLC | 4,270,074 | 2.12% | $12.46K | +560,573 | 0.01% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,139,532 | 2.05% | $12.09M | −377,074 | 0.01% |
| Nikko Asset Management Americas, Inc. | 4,132,534 | 2.05% | $12.07M | −384,072 | 0.16% |
| Silvercrest Asset Management Group LLC | 4,077,187 | 2.02% | $11.91M | −164,224 | 0.08% |
| Two Sigma Investments, LP | 3,484,633 | 1.73% | $10.18M | +739,612 | 0.01% |
| Silverarc Capital Management, LLC | 3,472,737 | 1.72% | $10.14M | +296,190 | 1.05% |
| Wasatch Advisors LP | 3,383,899 | 1.68% | $9.88M | −1,897,237 | 0.06% |
| Mackenzie Financial Corp | 3,002,694 | 1.49% | $8.77M | +2,961,958 | 0.01% |
| Vanguard Portfolio Management LLC | 2,768,990 | 1.37% | $8.09M | +849,923 | 0.00% |
| Soleus Capital Management, L.P. | 2,500,000 | 1.24% | $7.30M | −8,253,700 | 0.25% |
| Ieq Capital, LLC | 2,406,330 | 1.19% | $7.03M | −36,911 | 0.03% |
| Goldman Sachs Group Inc | 2,317,802 | 1.15% | $6.77M | −450,801 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 185 | 151M | 74.8% | 35 / 72 | 53 / 16 | 21M | 22M |
| Q1 2026 | 169 | 152M | 75.2% | 26 / 58 | 55 / 14 | 27M | 10M |
| Q4 2025 | 161 | 147M | 72.8% | 24 / 61 | 52 / 15 | 14M | 9M |
| Q3 2025 | 155 | 142M | 70.5% | 14 / 67 | 45 / 13 | 7M | 11M |
| Q2 2025 | 156 | 146M | 72.5% | 20 / 55 | 51 / 19 | 11M | 17M |
| Q1 2025 | 155 | 152M | 75.4% | 17 / 53 | 53 / 14 | 13M | 8M |
| Q4 2024 | 154 | 148M | 73.3% | 22 / 62 | 32 / 14 | 12M | 13M |
| Q3 2024 | 147 | 149M | 74.0% | 17 / 52 | 41 / 10 | 23M | 7M |
| Q2 2024 | 141 | 148M | 73.4% | 20 / 45 | 41 / 23 | 7M | 9M |
| Q1 2024 | 144 | 149M | 74.1% | 28 / 39 | 50 / 23 | 14M | 9M |
| Q4 2023 | 140 | 144M | 71.3% | 29 / 36 | 49 / 27 | 12M | 14M |
| Q3 2023 | 142 | 146M | 72.5% | 18 / 43 | 46 / 32 | 13M | 13M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CERS | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Innovation ETF | 8,284,570 | 4.11% | $17.81M | 0.32% | Jul 31, 2026 |
| ARK Genomic Revolution ETF | 7,223,126 | 3.58% | $15.53M | 1.00% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 6,075,566 | 3.01% | $17.74M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 5,183,366 | 2.57% | $15.14M | 0.02% | Jun 30, 2026 |
| Wasatch Ultra Growth Fund | 3,196,487 | 1.59% | $9.33M | 2.02% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,307,265 | 1.14% | $6.74M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,175,416 | 1.08% | $4.68M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,868,339 | 0.93% | $5.46M | 0.04% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 1,524,439 | 0.76% | $4.63M | 0.09% | May 29, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 1,208,271 | 0.60% | $3.53M | 0.06% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 998,953 | 0.50% | $3.04M | 0.01% | May 31, 2026 |
| iShares U.S. Small-Cap Equity Factor ETF | 965,854 | 0.48% | $2.08M | 0.05% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 950,460 | 0.47% | $2.89M | 0.02% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 917,893 | 0.46% | $2.79M | 0.01% | May 31, 2026 |
| Small Cap Core Portfolio | 857,210 | 0.43% | $2.50M | 0.29% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Mariner Greenman | President and CEO, Director | 5,154,955 | 2.56% | Jul 2, 2026 |
| Chrystal Jensen | Chief Legal Officer | 936,657 | 0.46% | Aug 17, 2026 |
| Vivek K. Jayaraman | Chief Executive Officer | 2,232,211 | 1.11% | Jul 20, 2026 |
| Kevin Dennis Green | Chief Financial Officer | 1,062,188 | 0.53% | Jul 2, 2026 |
| Richard J. Benjamin | Chief Medical Officer | 777,361 | 0.39% | Mar 16, 2026 |
| Eric Bjerkholt | Director | 261,679 | 0.13% | Jun 11, 2026 |
| Dean A. Gregory | Director | 146,725 | 0.07% | Jun 2, 2026 |
| Frank Witney | Director | 340,059 | 0.17% | Jun 2, 2026 |
| Jami K. Nachtsheim | Director | 268,362 | 0.13% | Jun 2, 2026 |
| Ann Lucena | Director | 232,284 | 0.12% | Jun 2, 2026 |
| Hua Shan | Director | 192,386 | 0.10% | Jun 2, 2026 |
| Timothy L. Moore | Director | 205,073 | 0.10% | Jun 4, 2025 |
| Daniel N. Swisher JR | Director | 207,045 | 0.10% | Jun 4, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Chrystal Jensen Chief Legal Officer | Aug 17, 2026 | Sale(10b5-1 plan) | −30,000 | $2.98 | $89.40K | 936,657 |
| Vivek K. Jayaraman Chief Executive Officer | Jul 16, 2026 | Sale(10b5-1 plan) | −16,666 | $3.16 | $52.66K | 2,232,211 |
| Vivek K. Jayaraman Chief Operating Officer | Jul 1, 2026 | Award | +554,529 | – | – | 2,248,877 |
| Vivek K. Jayaraman Chief Operating Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −42,359 | $2.94 | $124.54K | 1,694,348 |
| Vivek K. Jayaraman Chief Operating Officer | Jun 30, 2026 | Award | −80,000 | – | – | 1,736,707 |
| William Mariner Greenman President and CEO, Director | Jun 30, 2026 | Award | −192,500 | – | – | 5,154,955 |
| William Mariner Greenman President and CEO, Director | Jun 30, 2026 | Sale(10b5-1 plan) | −101,919 | $2.94 | $299.64K | 5,053,036 |
| Kevin Dennis Green Chief Financial Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −33,676 | $2.94 | $99.01K | 1,062,188 |
| Kevin Dennis Green Chief Financial Officer | Jun 30, 2026 | Award | −63,600 | – | – | 1,095,864 |
| Chrystal Jensen Chief Legal Officer | Jun 30, 2026 | Award | −55,000 | – | – | 990,986 |
| Chrystal Jensen Chief Legal Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −24,329 | $2.94 | $71.53K | 966,657 |
| Eric Bjerkholt Director | Jun 9, 2026 | Sale | −20,454 | $2.60 | $53.18K | 261,679 |
| Hua Shan Director | Jun 2, 2026 | Award | +60,000 | – | – | 192,386 |
| Frank Witney Director | Jun 2, 2026 | Award | +60,000 | – | – | 340,059 |
| Eric Bjerkholt Director | Jun 2, 2026 | Award | +60,000 | – | – | 282,133 |
| Dean A. Gregory Director | Jun 2, 2026 | Award | +60,000 | – | – | 146,725 |
| Jami K. Nachtsheim Director | Jun 2, 2026 | Award | +60,000 | – | – | 268,362 |
| Ann Lucena Director | Jun 2, 2026 | Award | +60,000 | – | – | 232,284 |
| Vivek K. Jayaraman Chief Operating Officer | May 29, 2026 | Sale(10b5-1 plan) | −16,667 | $3.00 | $50.00K | 1,656,707 |
| Vivek K. Jayaraman Chief Operating Officer | May 1, 2026 | Sale(10b5-1 plan) | −16,667 | $3.00 | $50.00K | 1,673,374 |
| Kevin Dennis Green Chief Financial Officer | Apr 1, 2026 | Award | +200,000 | – | – | 1,240,551 |
| Chrystal Jensen Chief Legal Officer | Apr 1, 2026 | Award | +200,000 | – | – | 1,146,131 |
| Kevin Dennis Green Chief Financial Officer | Mar 12, 2026 | Sale(10b5-1 plan) | −127,544 | $1.66 | $211.72K | 1,040,551 |
| Richard J. Benjamin Chief Medical Officer | Mar 12, 2026 | Sale(10b5-1 plan) | −101,740 | $1.66 | $168.89K | 777,361 |
| William Mariner Greenman President and CEO, Director | Mar 12, 2026 | Sale(10b5-1 plan) | −447,757 | $1.66 | $743.28K | 4,998,493 |
| Vivek K. Jayaraman Chief Operating Officer | Mar 12, 2026 | Sale(10b5-1 plan) | −165,200 | $1.66 | $274.23K | 1,747,674 |
| Richard J. Benjamin Chief Medical Officer | Mar 9, 2026 | Sale(10b5-1 plan) | −40,426 | $1.88 | $76.00K | 879,101 |
| Richard J. Benjamin Chief Medical Officer | Mar 9, 2026 | Sale(10b5-1 plan) | −40,426 | $1.88 | $76.00K | 879,101 |
| Richard J. Benjamin Chief Medical Officer | Mar 6, 2026 | Sale(10b5-1 plan) | −24,235 | $2.01 | $48.71K | 919,527 |
| William Mariner Greenman President and CEO, Director | Mar 6, 2026 | Sale(10b5-1 plan) | −78,187 | $2.01 | $157.16K | 5,446,250 |
| Richard J. Benjamin Chief Medical Officer | Mar 6, 2026 | Sale(10b5-1 plan) | −24,235 | $2.01 | $48.71K | 919,527 |
| Vivek K. Jayaraman Chief Operating Officer | Mar 6, 2026 | Sale(10b5-1 plan) | −34,094 | $2.01 | $68.53K | 1,912,874 |
| Chrystal Jensen Chief Legal Officer | Mar 6, 2026 | Sale(10b5-1 plan) | −30,845 | $2.01 | $62.00K | 1,059,139 |
| Kevin Dennis Green Chief Financial Officer | Mar 6, 2026 | Sale(10b5-1 plan) | −27,796 | $2.01 | $55.87K | 1,168,095 |
| Richard J. Benjamin Chief Medical Officer | Mar 5, 2026 | Sale(10b5-1 plan) | −61,233 | $2.06 | $126.14K | 943,762 |
| Richard J. Benjamin Chief Medical Officer | Mar 5, 2026 | Award | +55,220 | – | – | 1,004,995 |
| William Mariner Greenman President and CEO, Director | Mar 5, 2026 | Award | +193,270 | – | – | 5,524,437 |
| Richard J. Benjamin Chief Medical Officer | Mar 5, 2026 | Award | +55,220 | – | – | 1,004,995 |
| Richard J. Benjamin Chief Medical Officer | Mar 5, 2026 | Sale(10b5-1 plan) | −61,233 | $2.06 | $126.14K | 943,762 |
| Vivek K. Jayaraman Chief Operating Officer | Mar 5, 2026 | Award | +80,320 | – | – | 1,946,968 |
| Chrystal Jensen Chief Legal Officer | Mar 5, 2026 | Award | +55,220 | – | – | 1,083,514 |
| Kevin Dennis Green Chief Financial Officer | Mar 5, 2026 | Sale(10b5-1 plan) | −55,225 | $2.06 | $113.76K | 1,195,891 |
| Kevin Dennis Green Chief Financial Officer | Mar 5, 2026 | Award | +63,854 | – | – | 1,251,116 |
| Kevin Dennis Green Chief Financial Officer | Mar 2, 2026 | Award | +300,000 | – | – | 1,187,262 |
| William Mariner Greenman President and CEO, Director | Mar 2, 2026 | Award | +1,200,000 | – | – | 5,331,167 |
| Vivek K. Jayaraman Chief Operating Officer | Mar 2, 2026 | Award | +420,000 | – | – | 1,866,648 |
| Richard J. Benjamin Chief Medical Officer | Mar 2, 2026 | Award | +264,000 | – | – | 949,775 |
| Chrystal Jensen Chief Legal Officer | Mar 2, 2026 | Award | +300,000 | – | – | 1,028,294 |
| Chrystal Jensen Chief Legal Officer | Nov 24, 2025 | Sale(10b5-1 plan) | −55,000 | $1.70 | $93.50K | 728,294 |
| Dean A. Gregory Director | Aug 25, 2025 | Buy | +25,000 | $1.25 | $31.25K | 86,725 |
| Ann Lucena Director | Jun 3, 2025 | Award | +60,000 | – | – | 172,284 |
| Jami K. Nachtsheim Director | Jun 3, 2025 | Award | +60,000 | – | – | 208,362 |
| Daniel N. Swisher JR Director | Jun 3, 2025 | Award | +60,000 | – | – | 207,045 |
| Frank Witney Director | Jun 3, 2025 | Award | +60,000 | – | – | 280,059 |
| Timothy L. Moore Director | Jun 3, 2025 | Award | +60,000 | – | – | 205,073 |
| Hua Shan Director | Jun 3, 2025 | Award | +60,000 | – | – | 132,386 |
| Eric Bjerkholt Director | Jun 3, 2025 | Award | +60,000 | – | – | 222,133 |
| William Mariner Greenman President and CEO, Director | Mar 14, 2025 | Sale(10b5-1 plan) | −122,827 | $1.45 | $178.10K | 4,115,845 |
| Richard J. Benjamin Chief Medical Officer | Mar 14, 2025 | Sale(10b5-1 plan) | −30,075 | $1.45 | $43.61K | 685,775 |
| Kevin Dennis Green Chief Financial Officer | Mar 14, 2025 | Sale(10b5-1 plan) | −36,740 | $1.45 | $53.27K | 875,867 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Nikole Jensen Chrystal Officer | Aug 17, 2026 | 30,000 | $89.53K | Aug 17, 2026 | Restricted Stock |
| K. Jayaraman Vivek Officer | Jul 16, 2026 | 16,666 | $52.66K | Jul 16, 2026 | Restricted Stock |
| Bjerkholt Eric Director | Jun 9, 2026 | 20,454 | $53.18K | Jun 9, 2026 | Restricted Stock |
| K. Jayaraman Vivek Officer | May 29, 2026 | 16,667 | $50.00K | May 29, 2026 | Restricted Stock |
| J. Benjamin Richard Officer | May 1, 2026 | 76,209 | $214.63K | May 1, 2026 | Restricted Stock |
| K. Jayaraman Vivek Officer | May 1, 2026 | 16,667 | $50.00K | May 1, 2026 | Restricted Stock |
| J. Benjamin Richard Officer | Mar 9, 2026 | 40,426 | $76.03K | Mar 9, 2026 | Restricted Stock |
| J. Benjamin Richard Officer | Mar 5, 2026 | 61,233 | $126.30K | Mar 5, 2026 | Restricted Stock |
| D. Green Kevin Officer | Mar 5, 2026 | 55,225 | $113.90K | Mar 5, 2026 | Restricted Stock |
| Nikole Jensen Chrystal Officer | Nov 24, 2025 | 55,000 | $93.50K | Nov 24, 2025 | Restricted Stock |
| Chrystal Jensen Officer | Mar 4, 2025 | 60,000 | $90.00K | Mar 4, 2025 | RESTRICTED STOCK |
| J. Benjamin Richard Officer | Mar 3, 2025 | 51,254 | $80.82K | Mar 3, 2025 | Restricted Stock |
| D. Green Kevin Officer | Mar 3, 2025 | 60,656 | $95.65K | Mar 3, 2025 | Employee Stock Purchase Plan |
| Nikole Jensen Chrystal Officer | Dec 16, 2024 | 16,667 | $28.63K | Dec 16, 2024 | Restricted Stock |
| Eric Bjerkholt Director | Dec 12, 2024 | 20,000 | $35.70K | Dec 12, 2024 | OPEN MARKET |